Wide Range of resources on complex issues

We offer a wide range of resources on complex issues that impact all people with chronic conditions. Resources include member-specific services, frequent meetings and events, publications, and comments on rules and legislation.

Letter of Support for Dr. Robert Califf FDA Commissioner Nominee

12/13/2021

Califf Nomination Letter Final (PDF) December 13, 2021 The Honorable Patty Murray Chair Committee on Health, Education, Labor, and Pensions United States Senate 154 Russell

Our 2022 Policy Priorities

12/13/2021

Our 2022 Policy Priorities By: Jennifer Dexter, Director, Policy The National Health Council’s (NHC’s) policy matrix serves as a roadmap for our public policy initiatives.

NHC Board Approves 2022-2024 Strategic Plan

12/09/2021

NHC Board Approves 2022-2024 Strategic Plan By: Jennifer Schleman, Assistant Vice President, Marketing & Communications At its quarterly meeting earlier this week, the National Health

American Kidney Fund’s LaVarne Burton to Lead 2022 National Health Council Board of Directors

12/07/2021

2022 NHC Board News Release (PDF) (WASHINGTON, DC, December 7, 2021) At its annual membership meeting today, the National Health Council (NHC) elected its officers

It’s here! NHC Launches the Patient Experience Mapping Toolbox

12/06/2021

It’s here! NHC Launches the Patient Experience Mapping Toolbox By: Elisabeth Oehrlein, PhD, MS, Assistant Vice President, Research & Programs, and Silke Schoch, Manager, Research

Join Us in Raising Awareness for These Causes This December

12/01/2021

By Jennifer Schleman, Assistant Vice President, Marketing & Communications   Patient advocacy organizations work tirelessly to educate, promote, advocate, and raise awareness and funding for

NHC Comments on FDA-2020-D-2316 for Benefit-Risk Assessment for New Drug and Biological Products; Draft Guidance for Industry

11/29/2021

Food and Drug Administration Dockets Management Staff (HFA-305) 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 RE: FDA-2020-D-2316 for “Benefit-Risk Assessment for New Drug and

NHC RWE, EHR and Medical Claims Comments

11/29/2021

Dockets Management Staff Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane, Rm.1061 Rockville, MD 20852 RE: FDA Guidance, “Real-World Data:

House Passes Build Back Better Act

11/29/2021

House Passes Build Back Better Act By: Jennifer Dexter, Director, Policy On November 19, the House passed the $1.75 Trillion Build Back Better Act after